Related Experiment Video
Updated: Apr 13, 2026

05:58
Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
346
NDRG3-mediated lactate signaling in hypoxia
Kyung Chan Park1, Dong Chul Lee1, Young Il Yeom2
1Genome Structure Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 305-806, Korea.
BMB Reports
|May 5, 2015
Summary
Researchers discovered a lactate-dependent signaling pathway in hypoxia involving NDRG3 protein. Stabilized NDRG3 promotes angiogenesis and cell growth by activating the Raf-ERK pathway, offering therapeutic targets for hypoxia-related diseases.
Area of Science:
- Molecular Biology
- Cellular Physiology
- Biochemistry
Background:
- Hypoxia, a state of low oxygen, is implicated in numerous diseases and normal physiological processes.
- Understanding cellular responses to hypoxia is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the role of NDRG3 protein in hypoxia-induced signaling.
- To identify the regulatory mechanisms of NDRG3 under hypoxic conditions.
- To explore the therapeutic potential of targeting the NDRG3 pathway.
Main Methods:
- Investigated the regulation of NDRG3 protein expression and stability under varying oxygen and lactate levels.
- Utilized biochemical assays to determine the interaction between lactate and NDRG3.
- Examined the activation of the Raf-ERK pathway and its downstream effects on angiogenesis and cell growth.
Main Results:
- Identified NDRG3 as a key mediator of lactate-dependent signaling in hypoxia.
- Demonstrated that oxygen negatively regulates NDRG3 protein levels via the PHD2/VHL system.
- Showed that lactate stabilizes NDRG3 by inhibiting its proteasomal degradation, subsequently activating the Raf-ERK pathway.
- Confirmed that inhibiting lactate production abrogates NDRG3-mediated hypoxia responses.
Conclusions:
- The NDRG3-Raf-ERK axis represents a novel lactate-induced hypoxia signaling pathway.
- This pathway is critical for promoting angiogenesis and cell growth under hypoxic conditions.
- Targeting this axis offers potential therapeutic strategies for hypoxia-associated pathologies.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Hypoxia
2.6K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.6K
Inducible Operons: lac Operon
2.9K
The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA...
2.9K

